All COVID-19 articles
-
News Nano-sized cell particles are promising tool in treating infectious diseases
In a new study, extracellular vesicles were found to inhibit the viral infection of COVID-19 and potentially other infectious diseases.
-
NewsMink discovery challenges standard understanding of COVID-19 infection
Researchers studying zoonosis — the interspecies transmission of pathogens — in mink have found that TMPRSS2, an enzyme critical for viral fusion entry of SARS-CoV-2 in humans, is not functional in mink.
-
NewsLong-acting biologic has transmucosal transport properties that arrest Covid variants
Scientists report on a tailored ACE2 biologic, where ACE2 is fused to an engineered human albumin variant.
-
NewsYoung scientists spearhead breakthrough COVID-19 research
A molecular biophysics study investigates how coronavirus variants of concern attachment strength to human cells influences COVID-19’s spread and transmissibility.
-
NewsRisk of serious COVID-19 infection can now be predicted
Scientists have demonstrated a rapid rise in concentrations of platelet aggregates in patients admitted to intensive care with COVID-19 infections.
-
NewsSpike in premature births caused by COVID, and halted by vaccines
COVID-19 caused an alarming surge in premature births, but vaccines were key to returning the early birth rate to pre-pandemic levels, according to a new analysis of California birth records.
-
NewsWastewater testing improves predictions for COVID-19 hospital admissions
Testing wastewater for COVID-19 provides a better forecast of new COVID hospital admissions than clinical data, a new study suggests.
-
NewsCOVID vaccination before infection strongly linked to reduced risk of developing long covid
Unvaccinated individuals are almost four times as likely to be diagnosed than those vaccinated before first infection, new research shows.
-
NewsSimulation suggests mutant strains of COVID-19 emerged in response to human behavior
Using artificial intelligence technology and mathematical modeling, researchers have has revealed that human behavior, such as lockdowns and isolation measures, affect the evolution of new strains of COVID-19.
-
NewsAir cleaners don’t stop you getting sick, research shows
Air filtration systems do not reduce the risk of picking up viral infections, according to new research.
-
NewsFourth dose of COVID vaccine boosts protection in patients with rheumatic disease
A new study suggests that the recommendation for patients receiving disease-modifying antirheumatic drugs to receive a fourth dose of the mRNA vaccine has saved lives and reduced hospitalizations among patients in this high-risk group.
-
NewsTiny hinges bend the infection-spreading spikes of a coronavirus
Disabling those hinges could be a good strategy for designing vaccines and treatments against a broad range of coronavirus infections, including COVID-19.
-
NewsCOVID-19 compromised U.S. gains in controlling HIV and worsened health disparities
The COVID-19 pandemic slowed previous gains made in controlling HIV blood levels and worsened health disparities, according to researchers leading the largest U.S. evaluation of the impact of the public health crisis on people with HIV.
-
NewsOne in five patients experience rebound COVID after taking Paxlovid, new study finds
While Paxlovid remains a ‘life-saving drug,’ researchers found that patients experiencing virologic rebound after treatment may remain contagious.
-
NewsDifferent Covid antibodies target distinct regions of spike protein
Researchers found that Covid antibodies can be categorized into three types, each targeting distinct regions of the viral spike protein, a key component of the vaccine antigen.
-
NewsStudy to analyze how coronavirus spreads between wildlife and humans
The data will be used to create predictive models that can be used to prepare and protect human health for future variants and diseases.
-
NewsWHO updates its guidance on treatments for COVID-19
The new recommendations reflect the evolving nature of the virus and the changing role of Covid-19 therapies.
-
News Crowd-sourced potent SARS-CoV-2 antiviral lead compound announced by COVID Moonshot Consortium
More than 200 scientists and students, triggered by a Twitter appeal, have identified and developed novel compounds with excellent antiviral activity against a key enzyme of the SARS-COV-2 virus, the main protease (Mpro).
-
NewsLong COVID in women may be linked to inflammation levels at peak of infection
Women who have mild inflammation in the acute stages of COVID-19 infection may be more likely to experience a particular set of Long Covid symptoms, according to new research.
-
NewsResearchers develop a nasal vaccine that prevents COVID in preclinical studies
New protein-based technology triggers immunity to respiratory pathogens in the airway, before the disease reaches the bloodstream.
